Overview
X-linked lissencephaly with abnormal genitalia (XLAG), also known as X-linked lissencephaly with ambiguous genitalia, is a rare and severe brain malformation disorder caused by mutations in the ARX (Aristaless-Related Homeobox) gene located on the X chromosome. The condition predominantly affects males and is characterized by lissencephaly (a smooth brain surface due to absent or incomplete development of the normal folds and grooves of the cerebral cortex), which leads to profound intellectual disability and intractable epilepsy. The brain malformation in XLAG typically presents as a posterior-predominant lissencephaly with an abnormally thick cortex and absent corpus callosum (agenesis of the corpus callosum). In addition to the central nervous system involvement, affected males have abnormal genitalia, which can range from ambiguous genitalia to micropenis and cryptorchidism, reflecting disrupted development of the hypothalamic-pituitary-gonadal axis. Affected infants typically present in the neonatal period with severe seizures that are often refractory to treatment, poor feeding, hypothermia, and chronic diarrhea. Additional features may include neonatal hypoglycemia, pancreatic dysfunction with exocrine insufficiency, and hypothalamic dysfunction leading to temperature dysregulation. The prognosis is very poor, with most affected males dying in infancy or early childhood due to the severity of the neurological impairment and associated complications. Female carriers may be asymptomatic or may present with milder features such as agenesis of the corpus callosum, mild intellectual disability, or epilepsy. There is currently no cure or disease-modifying treatment for XLAG. Management is supportive and symptomatic, focusing on seizure control (though seizures are often highly resistant to antiepileptic medications), nutritional support, management of endocrine abnormalities, and palliative care. Genetic counseling is important for affected families, as carrier females have a 50% chance of transmitting the ARX mutation to their offspring.
Also known as:
Clinical phenotype terms— hover any for plain English:
X-linked recessive
Carried on the X chromosome; typically affects males more than females
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for X-linked lissencephaly with abnormal genitalia.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for X-linked lissencephaly with abnormal genitalia at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for X-linked lissencephaly with abnormal genitalia.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to X-linked lissencephaly with abnormal genitalia.
Community
No community posts yet. Be the first to share your experience with X-linked lissencephaly with abnormal genitalia.
Start the conversation →Latest news about X-linked lissencephaly with abnormal genitalia
No recent news articles for X-linked lissencephaly with abnormal genitalia.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about X-linked lissencephaly with abnormal genitalia
What is X-linked lissencephaly with abnormal genitalia?
X-linked lissencephaly with abnormal genitalia (XLAG), also known as X-linked lissencephaly with ambiguous genitalia, is a rare and severe brain malformation disorder caused by mutations in the ARX (Aristaless-Related Homeobox) gene located on the X chromosome. The condition predominantly affects males and is characterized by lissencephaly (a smooth brain surface due to absent or incomplete development of the normal folds and grooves of the cerebral cortex), which leads to profound intellectual disability and intractable epilepsy. The brain malformation in XLAG typically presents as a posterio
How is X-linked lissencephaly with abnormal genitalia inherited?
X-linked lissencephaly with abnormal genitalia follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does X-linked lissencephaly with abnormal genitalia typically begin?
Typical onset of X-linked lissencephaly with abnormal genitalia is neonatal. Age of onset can vary across affected individuals.